Global Veterinary Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Veterinary Vaccines estimated at US$ 7700.3 million in the year 2022, is projected to reach a revised size of US$ 11560 million by 2028, growing at a CAGR of 7.0% during the forecast period 2022-2028.

The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Veterinary Vaccines companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Veterinary Vaccines market. Further, it explains the major drivers and regional dynamics of the global Veterinary Vaccines market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Elanco

Merck

Merial

Zoetis

Advaxis

AmpliPhi Biosciences

Aratana Therapeutics

ARKO Labs

Bayer

CanFel Therapeutics

Ceva Animal Health

Colorado Serum

Epitopix

Genus

Hygieia Biological Laboratories

ImmuCell

Nexvet

Nuovo Biologics

UBI

Valneva

Vetoquinol

Virbac

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Inactivated Vaccines

Live Attenuated Vaccines

Conjugate Vaccines

Toxoid Vaccines

Recombinant Vaccines

DNA Vaccines

Others

Veterinary Clinic

Veterinary Hospital

Veterinary Research Institute

Retail Pharmacy

Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Veterinary Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Veterinary Vaccines market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Veterinary Vaccines, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Veterinary Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Vaccines revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Veterinary Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Veterinary Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Inactivated Vaccines

1.2.3 Live Attenuated Vaccines

1.2.4 Conjugate Vaccines

1.2.5 Toxoid Vaccines

1.2.6 Recombinant Vaccines

1.2.7 DNA Vaccines

1.2.8 Others

1.3 Market by Application

1.3.1 Global Veterinary Vaccines Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Veterinary Clinic

1.3.3 Veterinary Hospital

1.3.4 Veterinary Research Institute

1.3.5 Retail Pharmacy

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Veterinary Vaccines Market Size (2017-2028)

2.2 Veterinary Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Veterinary Vaccines Market Size by Region (2017-2022)

2.4 Global Veterinary Vaccines Market Size Forecast by Region (2023-2028)

2.5 Global Top Veterinary Vaccines Countries Ranking by Market Size

3.1 Global Veterinary Vaccines Revenue by Players

3.1.1 Global Veterinary Vaccines Revenue by Players (2017-2022)

3.1.2 Global Veterinary Vaccines Market Share by Players (2017-2022)

3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Veterinary Vaccines Revenue

3.4 Global Veterinary Vaccines Market Concentration Ratio

3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2021

3.5 Global Veterinary Vaccines Key Players Head office and Area Served

3.6 Key Players Veterinary Vaccines Product Solution and Service

3.7 Date of Enter into Veterinary Vaccines Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Veterinary Vaccines Historic Revenue by Type (2017-2022)

4.2 Global Veterinary Vaccines Forecasted Revenue by Type (2023-2028)

5.1 Global Veterinary Vaccines Historic Market Size by Application (2017-2022)

5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028)

6.1 North America Veterinary Vaccines Revenue by Company (2020-2022)

6.2 North America Veterinary Vaccines Revenue by Type (2017-2028)

6.3 North America Veterinary Vaccines Revenue by Application (2017-2028)

6.4 North America Veterinary Vaccines Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Veterinary Vaccines Revenue by Company (2020-2022)

7.2 Europe Veterinary Vaccines Revenue by Type (2017-2028)

7.3 Europe Veterinary Vaccines Revenue by Application (2017-2028)

7.4 Europe Veterinary Vaccines Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Veterinary Vaccines Revenue by Company (2020-2022)

8.2 Asia Pacific Veterinary Vaccines Revenue by Type (2017-2028)

8.3 Asia Pacific Veterinary Vaccines Revenue by Application (2017-2028)

8.4 Asia Pacific Veterinary Vaccines Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Veterinary Vaccines Revenue by Company (2020-2022)

9.2 Latin America Veterinary Vaccines Revenue by Type (2017-2028)

9.3 Latin America Veterinary Vaccines Revenue by Application (2017-2028)

9.4 Latin America Veterinary Vaccines Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Veterinary Vaccines Revenue by Company (2020-2022)

10.2 Middle East and Africa Veterinary Vaccines Revenue by Type (2017-2028)

10.3 Middle East and Africa Veterinary Vaccines Revenue by Application (2017-2028)

10.4 Middle East and Africa Veterinary Vaccines Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 Elanco

11.1.1 Elanco Company Details

11.1.2 Elanco Business Overview

11.1.3 Elanco Veterinary Vaccines Products and Services

11.1.4 Elanco Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.1.5 Elanco Veterinary Vaccines SWOT Analysis

11.1.6 Elanco Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Veterinary Vaccines Products and Services

11.2.4 Merck Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.2.5 Merck Veterinary Vaccines SWOT Analysis

11.2.6 Merck Recent Developments

11.3 Merial

11.3.1 Merial Company Details

11.3.2 Merial Business Overview

11.3.3 Merial Veterinary Vaccines Products and Services

11.3.4 Merial Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.3.5 Merial Veterinary Vaccines SWOT Analysis

11.3.6 Merial Recent Developments

11.4 Zoetis

11.4.1 Zoetis Company Details

11.4.2 Zoetis Business Overview

11.4.3 Zoetis Veterinary Vaccines Products and Services

11.4.4 Zoetis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.4.5 Zoetis Veterinary Vaccines SWOT Analysis

11.4.6 Zoetis Recent Developments

11.5 Advaxis

11.5.1 Advaxis Company Details

11.5.2 Advaxis Business Overview

11.5.3 Advaxis Veterinary Vaccines Products and Services

11.5.4 Advaxis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.5.5 Advaxis Veterinary Vaccines SWOT Analysis

11.5.6 Advaxis Recent Developments

11.6 AmpliPhi Biosciences

11.6.1 AmpliPhi Biosciences Company Details

11.6.2 AmpliPhi Biosciences Business Overview

11.6.3 AmpliPhi Biosciences Veterinary Vaccines Products and Services

11.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.6.5 AmpliPhi Biosciences Veterinary Vaccines SWOT Analysis

11.6.6 AmpliPhi Biosciences Recent Developments

11.7 Aratana Therapeutics

11.7.1 Aratana Therapeutics Company Details

11.7.2 Aratana Therapeutics Business Overview

11.7.3 Aratana Therapeutics Veterinary Vaccines Products and Services

11.7.4 Aratana Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.7.5 Aratana Therapeutics Veterinary Vaccines SWOT Analysis

11.7.6 Aratana Therapeutics Recent Developments

11.8 ARKO Labs

11.8.1 ARKO Labs Company Details

11.8.2 ARKO Labs Business Overview

11.8.3 ARKO Labs Veterinary Vaccines Products and Services

11.8.4 ARKO Labs Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.8.5 ARKO Labs Veterinary Vaccines SWOT Analysis

11.8.6 ARKO Labs Recent Developments

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Veterinary Vaccines Products and Services

11.9.4 Bayer Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.9.5 Bayer Veterinary Vaccines SWOT Analysis

11.9.6 Bayer Recent Developments

11.10 CanFel Therapeutics

11.10.1 CanFel Therapeutics Company Details

11.10.2 CanFel Therapeutics Business Overview

11.10.3 CanFel Therapeutics Veterinary Vaccines Products and Services

11.10.4 CanFel Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.10.5 CanFel Therapeutics Veterinary Vaccines SWOT Analysis

11.10.6 CanFel Therapeutics Recent Developments

11.11 Ceva Animal Health

11.11.1 Ceva Animal Health Company Details

11.11.2 Ceva Animal Health Business Overview

11.11.3 Ceva Animal Health Veterinary Vaccines Products and Services

11.11.4 Ceva Animal Health Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.11.5 Ceva Animal Health Recent Developments

11.12 Colorado Serum

11.12.1 Colorado Serum Company Details

11.12.2 Colorado Serum Business Overview

11.12.3 Colorado Serum Veterinary Vaccines Products and Services

11.12.4 Colorado Serum Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.12.5 Colorado Serum Recent Developments

11.13 Epitopix

11.13.1 Epitopix Company Details

11.13.2 Epitopix Business Overview

11.13.3 Epitopix Veterinary Vaccines Products and Services

11.13.4 Epitopix Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.13.5 Epitopix Recent Developments

11.14 Genus

11.14.1 Genus Company Details

11.14.2 Genus Business Overview

11.14.3 Genus Veterinary Vaccines Products and Services

11.14.4 Genus Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.14.5 Genus Recent Developments

11.15 Hygieia Biological Laboratories

11.15.1 Hygieia Biological Laboratories Company Details

11.15.2 Hygieia Biological Laboratories Business Overview

11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Products and Services

11.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.15.5 Hygieia Biological Laboratories Recent Developments

11.16 ImmuCell

11.16.1 ImmuCell Company Details

11.16.2 ImmuCell Business Overview

11.16.3 ImmuCell Veterinary Vaccines Products and Services

11.16.4 ImmuCell Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.16.5 ImmuCell Recent Developments

11.17 Nexvet

11.17.1 Nexvet Company Details

11.17.2 Nexvet Business Overview

11.17.3 Nexvet Veterinary Vaccines Products and Services

11.17.4 Nexvet Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.17.5 Nexvet Recent Developments

11.18 Nuovo Biologics

11.18.1 Nuovo Biologics Company Details

11.18.2 Nuovo Biologics Business Overview

11.18.3 Nuovo Biologics Veterinary Vaccines Products and Services

11.18.4 Nuovo Biologics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.18.5 Nuovo Biologics Recent Developments

11.19 UBI

11.19.1 UBI Company Details

11.19.2 UBI Business Overview

11.19.3 UBI Veterinary Vaccines Products and Services

11.19.4 UBI Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.19.5 UBI Recent Developments

11.20 Valneva

11.20.1 Valneva Company Details

11.20.2 Valneva Business Overview

11.20.3 Valneva Veterinary Vaccines Products and Services

11.20.4 Valneva Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.20.5 Valneva Recent Developments

11.21 Vetoquinol

11.21.1 Vetoquinol Company Details

11.21.2 Vetoquinol Business Overview

11.21.3 Vetoquinol Veterinary Vaccines Products and Services

11.21.4 Vetoquinol Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.21.5 Vetoquinol Recent Developments

11.22 Virbac

11.22.1 Virbac Company Details

11.22.2 Virbac Business Overview

11.22.3 Virbac Veterinary Vaccines Products and Services

11.22.4 Virbac Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)

11.22.5 Virbac Recent Developments

12.1 Veterinary Vaccines Market Trends

12.2 Veterinary Vaccines Market Drivers

12.3 Veterinary Vaccines Market Challenges

12.4 Veterinary Vaccines Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Inactivated Vaccines

    Table 3. Key Players of Live Attenuated Vaccines

    Table 4. Key Players of Conjugate Vaccines

    Table 5. Key Players of Toxoid Vaccines

    Table 6. Key Players of Recombinant Vaccines

    Table 7. Key Players of DNA Vaccines

    Table 8. Key Players of Others

    Table 9. Global Veterinary Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 10. Global Veterinary Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 11. Global Veterinary Vaccines Revenue by Region (2017-2022) & (US$ Million)

    Table 12. Global Veterinary Vaccines Revenue Market Share by Region (2017-2022)

    Table 13. Global Veterinary Vaccines Revenue by Players (2017-2022) & (US$ Million)

    Table 14. Global Veterinary Vaccines Market Share by Players (2017-2022)

    Table 15. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)

    Table 16. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2021

    Table 17. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2017-2022)

    Table 18. Key Players Headquarters and Area Served

    Table 19. Key Players Veterinary Vaccines Product Solution and Service

    Table 20. Date of Key Manufacturers Enter into Veterinary Vaccines Market

    Table 21. Mergers & Acquisitions, Expansion Plans

    Table 22. Global Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)

    Table 23. Global Veterinary Vaccines Revenue Market Share by Type (2017-2022)

    Table 24. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 25. Global Veterinary Vaccines Revenue Market Share by Type (2023-2028)

    Table 26. Global Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)

    Table 27. Global Veterinary Vaccines Revenue Market Share by Application (2017-2022)

    Table 28. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 29. Global Veterinary Vaccines Revenue Market Share by Application (2023-2028)

    Table 30. North America Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)

    Table 31. North America Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)

    Table 32. North America Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)

    Table 33. North America Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)

    Table 34. North America Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)

    Table 35. North America Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)

    Table 36. North America Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)

    Table 37. Europe Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)

    Table 38. Europe Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)

    Table 39. Europe Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)

    Table 40. Europe Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)

    Table 41. Europe Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)

    Table 42. Europe Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)

    Table 43. Europe Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)

    Table 45. Asia Pacific Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)

    Table 49. Asia Pacific Veterinary Vaccines Revenue by Region (2017-2022) & (US$ Million)

    Table 50. Asia Pacific Veterinary Vaccines Revenue by Region (2023-2028) & (US$ Million)

    Table 51. Latin America Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)

    Table 52. Latin America Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)

    Table 53. Latin America Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)

    Table 54. Latin America Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)

    Table 55. Latin America Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)

    Table 56. Latin America Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)

    Table 57. Latin America Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)

    Table 59. Middle East and Africa Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)

    Table 61. Middle East and Africa Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)

    Table 62. Middle East and Africa Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)

    Table 63. Middle East and Africa Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)

    Table 64. Middle East and Africa Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)

    Table 65. Elanco Company Details

    Table 66. Elanco Business Overview

    Table 67. Elanco Veterinary Vaccines Product and Services

    Table 68. Elanco Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 69. Elanco Veterinary Vaccines SWOT Analysis

    Table 70. Elanco Recent Developments

    Table 71. Merck Company Details

    Table 72. Merck Business Overview

    Table 73. Merck Veterinary Vaccines Product and Services

    Table 74. Merck Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 75. Merck Veterinary Vaccines SWOT Analysis

    Table 76. Merck Recent Developments

    Table 77. Merial Company Details

    Table 78. Merial Business Overview

    Table 79. Merial Veterinary Vaccines Product and Services

    Table 80. Merial Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 81. Merial Veterinary Vaccines SWOT Analysis

    Table 82. Merial Recent Developments

    Table 83. Zoetis Company Details

    Table 84. Zoetis Business Overview

    Table 85. Zoetis Veterinary Vaccines Product and Services

    Table 86. Zoetis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 87. Zoetis Veterinary Vaccines SWOT Analysis

    Table 88. Zoetis Recent Developments

    Table 89. Advaxis Company Details

    Table 90. Advaxis Business Overview

    Table 91. Advaxis Veterinary Vaccines Product and Services

    Table 92. Advaxis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 93. Advaxis Veterinary Vaccines SWOT Analysis

    Table 94. Advaxis Recent Developments

    Table 95. AmpliPhi Biosciences Company Details

    Table 96. AmpliPhi Biosciences Business Overview

    Table 97. AmpliPhi Biosciences Veterinary Vaccines Product and Services

    Table 98. AmpliPhi Biosciences Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 99. AmpliPhi Biosciences Veterinary Vaccines SWOT Analysis

    Table 100. AmpliPhi Biosciences Recent Developments

    Table 101. Aratana Therapeutics Company Details

    Table 102. Aratana Therapeutics Business Overview

    Table 103. Aratana Therapeutics Veterinary Vaccines Product and Services

    Table 104. Aratana Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 105. Aratana Therapeutics Veterinary Vaccines SWOT Analysis

    Table 106. Aratana Therapeutics Recent Developments

    Table 107. ARKO Labs Company Details

    Table 108. ARKO Labs Business Overview

    Table 109. ARKO Labs Veterinary Vaccines Product and Services

    Table 110. ARKO Labs Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 111. ARKO Labs Veterinary Vaccines SWOT Analysis

    Table 112. ARKO Labs Recent Developments

    Table 113. Bayer Company Details

    Table 114. Bayer Business Overview

    Table 115. Bayer Veterinary Vaccines Product and Services

    Table 116. Bayer Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 117. Bayer Veterinary Vaccines SWOT Analysis

    Table 118. Bayer Recent Developments

    Table 119. CanFel Therapeutics Company Details

    Table 120. CanFel Therapeutics Business Overview

    Table 121. CanFel Therapeutics Veterinary Vaccines Product and Services

    Table 122. CanFel Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 123. CanFel Therapeutics Veterinary Vaccines SWOT Analysis

    Table 124. CanFel Therapeutics Recent Developments

    Table 125. Ceva Animal Health Company Details

    Table 126. Ceva Animal Health Business Overview

    Table 127. Ceva Animal Health Veterinary Vaccines Product and Services

    Table 128. Ceva Animal Health Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 129. Ceva Animal Health Recent Developments

    Table 130. Colorado Serum Company Details

    Table 131. Colorado Serum Business Overview

    Table 132. Colorado Serum Veterinary Vaccines Product and Services

    Table 133. Colorado Serum Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 134. Colorado Serum Recent Developments

    Table 135. Epitopix Company Details

    Table 136. Epitopix Business Overview

    Table 137. Epitopix Veterinary Vaccines Product and Services

    Table 138. Epitopix Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 139. Epitopix Recent Developments

    Table 140. Genus Company Details

    Table 141. Genus Business Overview

    Table 142. Genus Veterinary Vaccines Product and Services

    Table 143. Genus Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 144. Genus Recent Developments

    Table 145. Hygieia Biological Laboratories Company Details

    Table 146. Hygieia Biological Laboratories Business Overview

    Table 147. Hygieia Biological Laboratories Veterinary Vaccines Product and Services

    Table 148. Hygieia Biological Laboratories Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 149. Hygieia Biological Laboratories Recent Developments

    Table 150. ImmuCell Company Details

    Table 151. ImmuCell Business Overview

    Table 152. ImmuCell Veterinary Vaccines Product and Services

    Table 153. ImmuCell Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 154. ImmuCell Recent Developments

    Table 155. Nexvet Company Details

    Table 156. Nexvet Business Overview

    Table 157. Nexvet Veterinary Vaccines Product and Services

    Table 158. Nexvet Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 159. Nexvet Recent Developments

    Table 160. Nuovo Biologics Company Details

    Table 161. Nuovo Biologics Business Overview

    Table 162. Nuovo Biologics Veterinary Vaccines Product and Services

    Table 163. Nuovo Biologics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 164. Nuovo Biologics Recent Developments

    Table 165. UBI Company Details

    Table 166. UBI Business Overview

    Table 167. UBI Veterinary Vaccines Product and Services

    Table 168. UBI Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 169. UBI Recent Developments

    Table 170. Valneva Company Details

    Table 171. Valneva Business Overview

    Table 172. Valneva Veterinary Vaccines Product and Services

    Table 173. Valneva Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 174. Valneva Recent Developments

    Table 175. Vetoquinol Company Details

    Table 176. Vetoquinol Business Overview

    Table 177. Vetoquinol Veterinary Vaccines Product and Services

    Table 178. Vetoquinol Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 179. Vetoquinol Recent Developments

    Table 180. Virbac Company Details

    Table 181. Virbac Business Overview

    Table 182. Virbac Veterinary Vaccines Product and Services

    Table 183. Virbac Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)

    Table 184. Virbac Recent Developments

    Table 185. Veterinary Vaccines Market Trends

    Table 186. Veterinary Vaccines Market Drivers

    Table 187. Veterinary Vaccines Market Challenges

    Table 188. Veterinary Vaccines Market Restraints

    Table 189. Research Programs/Design for This Report

    Table 190. Key Data Information from Secondary Sources

    Table 191. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Veterinary Vaccines Sales Market Share by Type: 2021 VS 2028

    Figure 2. Inactivated Vaccines Features

    Figure 3. Live Attenuated Vaccines Features

    Figure 4. Conjugate Vaccines Features

    Figure 5. Toxoid Vaccines Features

    Figure 6. Recombinant Vaccines Features

    Figure 7. DNA Vaccines Features

    Figure 8. Others Features

    Figure 9. Global Veterinary Vaccines Sales Market Share by Application: 2021 VS 2028

    Figure 10. Veterinary Clinic Case Studies

    Figure 11. Veterinary Hospital Case Studies

    Figure 12. Veterinary Research Institute Case Studies

    Figure 13. Retail Pharmacy Case Studies

    Figure 14. Others Case Studies

    Figure 15. Veterinary Vaccines Report Years Considered

    Figure 16. Global Veterinary Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 17. Global Veterinary Vaccines Market Size 2017-2028 (US$ Million)

    Figure 18. Global Veterinary Vaccines Market Size Market Share by Region: 2021 VS 2028

    Figure 19. Global Veterinary Vaccines Revenue Market Share by Region in 2017 VS 2022

    Figure 20. Global Top 10 Veterinary Vaccines Countries Ranking by Market Size (US$ Million) in 2021

    Figure 21. Global Veterinary Vaccines Market Share by Players in 2021

    Figure 22. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)

    Figure 23. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021

    Figure 24. North America Veterinary Vaccines Revenue Market Share by Company in 2021

    Figure 25. North America Veterinary Vaccines Revenue Market Share by Type (2017-2028)

    Figure 26. North America Veterinary Vaccines Revenue Market Share by Application (2017-2028)

    Figure 27. North America Veterinary Vaccines Revenue Share by Country (2017-2028)

    Figure 28. U.S. Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 29. Canada Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 30. Europe Veterinary Vaccines Revenue Market Share by Company in 2021

    Figure 31. Europe Veterinary Vaccines Revenue Market Share by Type (2017-2028)

    Figure 32. Europe Veterinary Vaccines Revenue Market Share by Application (2017-2028)

    Figure 33. Europe Veterinary Vaccines Revenue Share by Country (2017-2028)

    Figure 34. Germany Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 35. France Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 36. U.K. Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 37. Italy Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 38. Russia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 39. Asia Pacific Veterinary Vaccines Revenue Market Share by Company in 2021

    Figure 40. Asia Pacific Veterinary Vaccines Revenue Market Share by Type (2017-2028)

    Figure 41. Asia Pacific Veterinary Vaccines Revenue Market Share by Application (2017-2028)

    Figure 42. Asia Pacific Veterinary Vaccines Revenue Share by Region (2017-2028)

    Figure 43. China Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 44. Japan Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 45. South Korea Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 46. India Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 47. Australia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 48. Taiwan Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 49. Indonesia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 50. Thailand Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 51. Malaysia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 52. Philippines Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 53. Vietnam Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 54. Latin America Veterinary Vaccines Revenue Market Share by Company in 2021

    Figure 55. Latin America Veterinary Vaccines Revenue Market Share by Type (2017-2028)

    Figure 56. Latin America Veterinary Vaccines Revenue Market Share by Application (2017-2028)

    Figure 57. Latin America Veterinary Vaccines Revenue Share by Country (2017-2028)

    Figure 58. Mexico Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 59. Brazil Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 60. Argentina Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 61. Middle East and Africa Veterinary Vaccines Revenue Market Share by Company in 2021

    Figure 62. Middle East and Africa Veterinary Vaccines Revenue Market Share by Type (2017-2028)

    Figure 63. Middle East and Africa Veterinary Vaccines Revenue Market Share by Application (2017-2028)

    Figure 64. Middle East and Africa Veterinary Vaccines Revenue Share by Country (2017-2028)

    Figure 65. Turkey Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 66. Saudi Arabia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 67. U.A.E Veterinary Vaccines Revenue (2017-2028) & (US$ Million)

    Figure 68. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 69. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 70. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 71. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 72. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 73. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 74. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 75. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 76. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 77. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 78. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 79. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 80. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 81. Genus Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 82. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 83. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 84. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 85. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 86. UBI Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 87. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 88. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 89. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)

    Figure 90. Bottom-up and Top-down Approaches for This Report

    Figure 91. Data Triangulation

    Figure 92. Key Executives Interviewed